Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH06101994B2 - Digestion-resistant enteric useful bacteria and method for producing the same - Google Patents
[go: Go Back, main page]

JPH06101994B2 - Digestion-resistant enteric useful bacteria and method for producing the same - Google Patents

Digestion-resistant enteric useful bacteria and method for producing the same

Info

Publication number
JPH06101994B2
JPH06101994B2 JP1210102A JP21010289A JPH06101994B2 JP H06101994 B2 JPH06101994 B2 JP H06101994B2 JP 1210102 A JP1210102 A JP 1210102A JP 21010289 A JP21010289 A JP 21010289A JP H06101994 B2 JPH06101994 B2 JP H06101994B2
Authority
JP
Japan
Prior art keywords
capsule
digestive
resistant
useful bacterium
polyhydric alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP1210102A
Other languages
Japanese (ja)
Other versions
JPH0376561A (en
Inventor
定司 山下
Original Assignee
ユニコロイド株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニコロイド株式会社 filed Critical ユニコロイド株式会社
Priority to JP1210102A priority Critical patent/JPH06101994B2/en
Publication of JPH0376561A publication Critical patent/JPH0376561A/en
Publication of JPH06101994B2 publication Critical patent/JPH06101994B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、ビフィズス菌群のように大腸内において人体
に有用な作用を有する細菌を胃腸で失活させることなく
大腸に到達させる耐消化性腸内有用細菌及びその製法に
関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial field of application] The present invention provides a digestion resistance that allows bacteria having a useful effect on the human body in the large intestine, such as the group of Bifidobacterium, to reach the large intestine without being inactivated in the gastrointestinal tract. The present invention relates to useful enteric bacteria and a method for producing the same.

〔従来の技術〕[Conventional technology]

腸内有用細菌であるビフィズス菌群は嫌気性菌であり、
酸素、酸及び湿度に弱い。人種、環境、年齢等によりビ
フィズス菌群の量は異なるが、空腸、回腸、盲腸、直腸
に存在し、特に大腸部位に多く存在することが判明して
いる。大腸のビフィズス菌群が大腸に存在すると、大腸
内の細菌相が理想的に保たれ、病原菌の腸内感染を予防
し、下痢を予防及び治療し、宿便が解消し、成人病を予
防し、免疫力を高めるなどの効果があり、一般に個体の
加齢に伴いビフィズス菌の量が減少する傾向がある。
(光岡知足、製薬工場、VOL.6,No.5(1986),P.424〜48
8) このようなビフィズス菌群を大腸内に大量に繁殖させる
べく、経口的に食品と共に外部から供給する方法は種々
検討されている。しかしながら、従来の方法はすべてビ
フィズス菌を液状、ペースト状、粉状、顆粒状、錠剤な
どの形態で投与してきたため、胃内部を通過する際、胃
粘膜より産生される強酸性の胃液により失活し、腸内到
達以前にビフィズス菌はその効力を失っていた。
Bifidobacteria that are useful enteric bacteria are anaerobic bacteria,
Sensitive to oxygen, acids and humidity. Although the amount of the bifidobacteria group varies depending on race, environment, age, etc., it has been found that it is present in the jejunum, ileum, cecum, and rectum, especially in the large intestine. When the Bifidobacterium group of the large intestine is present in the large intestine, the bacterial flora in the large intestine is ideally maintained, the intestinal infection of the pathogenic bacterium is prevented, diarrhea is prevented and treated, bowel movement is eliminated, and adult diseases are prevented. It has effects such as enhancing immunity, and generally the amount of bifidobacteria tends to decrease as the individual ages.
(Michioka Chizu, Pharmaceutical Factory, VOL.6, No.5 (1986), P.424 ~ 48
8) In order to propagate a large amount of such Bifidobacteria in the large intestine, various methods of orally supplying from the outside with food have been studied. However, since all the conventional methods have administered bifidobacteria in the form of liquid, paste, powder, granules, tablets, etc., they are inactivated by the strongly acidic gastric juice produced by the gastric mucosa when passing through the stomach. However, Bifidobacterium had lost its efficacy before reaching the intestine.

〔発明が解決しようとする課題〕[Problems to be Solved by the Invention]

経口的に投与されたビフィズス菌群が胃内を通過する際
に、失活されないようにビフィズス菌を保護し、腸内特
に大腸に到達させ、大腸で大量のビフィズス菌が放出さ
れる技術が求められていた。
When a group of orally administered bifidobacteria passes through the stomach, it protects the bifidobacteria so that they are not inactivated and reaches the intestine, especially the large intestine, where a large amount of bifidobacteria is released in the large intestine. It was being done.

〔課題解決の手段〕[Means for solving problems]

本発明は上記課題を解決するものであって、その構成
は、腸内有用細菌が、天然多糖類・多価アルコール組成
物からなるフィルム製のカプセルに充填され、該カプセ
ルが胃内温度以上の融点を有する食用油脂で被覆されて
いることを特徴とする。
The present invention is to solve the above-mentioned problems, and the composition thereof is such that useful enteric bacteria are filled in a capsule made of a film composed of a natural polysaccharide / polyhydric alcohol composition, and the capsule has a temperature of gastric temperature or higher. It is characterized by being coated with an edible oil / fat having a melting point.

本発明における腸内有用細菌とは、ビフィズス菌に限定
されるものではなく、乳酸菌、連鎖状球菌属であるフエ
カリス、乳酸杆菌属であるアシドフイルス等腸内細菌相
を良好に保つものは全て包含される。中でもビフィズス
菌属で代表されるロンガムが好ましい。
Intestinal useful bacteria in the present invention is not limited to bifidobacteria, lactic acid bacteria, Streptococcus genus Feucaris, Lactobacillus acidophilus such as all those that keep good intestinal bacterial flora are included. It Among them, longum typified by Bifidobacteria is preferable.

腸内有用細菌はカプセルに収納する。カプセルは更にそ
の表面が食用油脂で被覆されているため、胃内における
消化のおそれはないが、胃内で破袋しないだけの剛性或
いは強度を有する可食性物質である。中でも、小腸内に
おいても消化されない非消化性の素材が好ましい。
Useful bacteria in the intestine are stored in capsules. Since the surface of the capsule is further covered with edible oil and fat, there is no risk of digestion in the stomach, but it is an edible substance having rigidity or strength that does not cause bag breakage in the stomach. Above all, a non-digestible material that is not digested even in the small intestine is preferable.

本発明におけるカプセル素材は、特開昭60−267273号公
報、特開昭63−28380号公報及び特公平4−57305号公報
に開示されており、多価アルコール、糖アルコール、単
糖類、二糖類及びオリゴ糖から選ばれた少なくとも1種
の濃厚溶液の中で、カラギナン、カルギン酸、アルギン
酸誘導体、寒天、ローカストビーンガム、グアーガム、
タマリンド種子多糖類、ペクチン、キサンタンガム、グ
ルコマンナン、キチン質、プルランから選ばれた少なく
とも1種の天然多糖類をアルカリの存在下または非存在
下に均一に混練して得られた天然多糖類・多価アルコー
ル組成物を使用する。
The capsule material in the present invention is disclosed in JP-A-60-267273, JP-A-63-28380 and JP-B-4-57305, and polyhydric alcohols, sugar alcohols, monosaccharides and disaccharides. And in at least one concentrated solution selected from oligosaccharides, carrageenan, carginic acid, alginic acid derivative, agar, locust bean gum, guar gum,
A natural polysaccharide / polysaccharide obtained by uniformly kneading at least one natural polysaccharide selected from tamarind seed polysaccharide, pectin, xanthan gum, glucomannan, chitin and pullulan in the presence or absence of an alkali. A polyhydric alcohol composition is used.

カプセルの製法としては、例えば、上記素材の濃厚水溶
液にカプセルの型を浸漬し、乾燥させてもよく、前もっ
て製造したシートを加熱圧縮して一定の型に成形しても
よい。
As a method for producing the capsule, for example, the capsule die may be dipped in a concentrated aqueous solution of the above material and dried, or the sheet produced in advance may be heated and compressed to be formed into a certain die.

カプセルには複数の微細な孔を穿設する。孔の大きさは
素材の種類、厚さによっても異なるが、細菌が自由に通
過できる大きさであり、0.1〜5μ好ましくは0.5〜3μ
である。孔を設けるにあたっては、カプセルの型内に複
数の針状物を自由に突出させたり、収納したりできる装
置を設けカプセル成形の際は突出させ、脱型の際は収納
させればカプセル成形と同時に複数の孔を設けることが
できる。或いはカプセル成形後に孔を設けてもよく、熱
針による機械的方法、レーザービーム等による方法もあ
る。更に本発明の天然多糖類・多価アルコール組成物の
中に消化性素材からなる微粒子を少量配合してカプセル
を成形してもよい。この場合には小腸内において消化性
素材が消化消滅し、その後に複数の孔が設けられる。こ
の方法を採用することにより、小腸の末端あたりから比
較的早い時期に内容物を放出させることができる。
The capsule is provided with a plurality of fine holes. The size of the pores varies depending on the type and thickness of the material, but it is the size that allows bacteria to freely pass, and is 0.1 to 5μ, preferably 0.5 to 3μ.
Is. When forming the holes, a device that allows the needles to freely project or store a plurality of needle-shaped objects in the mold of the capsule is provided so that they are projected when the capsule is molded and stored when the mold is removed. Multiple holes can be provided at the same time. Alternatively, holes may be provided after capsule formation, and there are also a mechanical method using a hot needle and a method using a laser beam. Furthermore, a small amount of fine particles made of a digestible material may be added to the natural polysaccharide / polyhydric alcohol composition of the present invention to form a capsule. In this case, the digestible material is digested and extinguished in the small intestine, and then a plurality of holes are provided. By adopting this method, the contents can be released relatively early from the end of the small intestine.

また、特に孔を設けなくとも本発明のカプセル素材が水
分により膨潤し、揉まれることにより自然に亀裂や穿孔
が生じ、大腸において確実に腸内有用細菌を放出するこ
とができる。
Further, even if no pores are provided, the capsule material of the present invention swells with water and is rubbed, whereby cracks and perforations naturally occur, and intestinal useful bacteria can be reliably released in the large intestine.

更に、胃内通過中にカプセル中に胃液が浸透するのを防
ぐために、カプセル外表面に食用油脂を緻密に被覆す
る。食用油脂は胃内温度により脱落しない溶融温度を要
し、35℃以上、好ましくは、45〜60℃である。現実には
食用硬化油脂、牛脂、豚脂などが好ましく使用される。
Furthermore, in order to prevent gastric juice from penetrating into the capsule during passage through the stomach, the outer surface of the capsule is densely coated with edible oil and fat. Edible fats and oils need to have a melting temperature that does not fall off due to the temperature in the stomach, and are 35 ° C or higher, preferably 45 to 60 ° C. In reality, hardened edible fats, beef tallow, lard and the like are preferably used.

このようにしてカプセルは胃液の直接接触から保護され
て腸内に到達する。腸内において油脂は胃リバーゼ、腸
リバーゼ、膵リバーゼ、胆汁などの作用により消化さ
れ、カプセルが露出する。カプセルが蛋白質、消化性多
糖類などの消化性素材であれば小腸内でビフィズス菌は
すべて放出される。小腸は消化作用が強く、ビフィズス
菌にとって好環境ではないため、小腸内での放出を最小
に止め、大腸まで到達させることが好ましい。本発明は
非消化性、且つ細菌透過性のカプセル素材を用いている
ため、小腸から大腸にいたる間連続的にビフィズス菌を
放出し続け、大腸に多数のビフィズス菌を到達させるこ
とができる。
In this way the capsule reaches the intestine protected from direct contact with gastric juice. In the intestines, oils and fats are digested by the action of gastric reversal, intestinal revertase, pancreatic revertase, bile, etc., and the capsule is exposed. If the capsule is a digestive material such as protein or digestive polysaccharide, all Bifidobacteria are released in the small intestine. Since the small intestine has a strong digestive action and is not a favorable environment for Bifidobacterium, it is preferable to minimize the release in the small intestine and reach the large intestine. Since the present invention uses a non-digestible and bacteria-permeable capsule material, it is possible to continuously release bifidobacteria from the small intestine to the large intestine, and to allow a large number of bifidobacteria to reach the large intestine.

大腸内に到達したビフィズス菌が更に増殖するために、
食用油脂で被覆したカプセルをビフィズス菌の増殖促進
要素であるフラクトオリゴ糖を主成分とする調味物質で
被覆することが好ましい。フラクトオリゴ糖はシューク
ロース1分子にフラクトース1〜4分子が結合した構造
であり、低カロリー甘味料としても使用される。
In order for the bifidobacteria that have reached the large intestine to grow further,
It is preferable that the capsule coated with edible oil and fat is coated with a seasoning substance containing fructooligosaccharide, which is a growth-promoting element of bifidobacteria, as a main component. Fructooligosaccharide has a structure in which 1 molecule of fructose is bound to 1 molecule of sucrose and is also used as a low-calorie sweetener.

〔作用〕[Action]

本発明はビフィズス菌群を可食性かつ非消化性の天然多
糖類・多価アルコール組成物からなるカプセルに収納
し、これを胃酸から保護するために胃内温度で溶解しな
い可食性油脂で被覆したものである。小腸に到達後は油
脂は消化され、カプセルが露出する。この際、カプセル
が非消化性で且つ細菌を通過させ得る素材であるため、
カプセルの形態が小腸に至っても崩壊しないため、ビフ
ィズス菌は孔から徐々に放出され、大腸まで到達し、更
に放出し続ける。そのため、経口的に大腸に大量のビフ
ィズス菌を到達させることが可能になり、腸内の細菌相
を理想的に維持することが可能になった。更に、食用油
脂をフラクトオリゴ糖で被覆すると摂取に際し口あたり
がよいばかりでなく、腸内到達後のビフィズス菌群増殖
要素であり、ビフィズス菌が一層活性化する。
The present invention stores a group of bifidobacteria in a capsule composed of an edible and non-digestible natural polysaccharide / polyhydric alcohol composition, and coats it with an edible oil that does not dissolve at gastric temperature to protect it from gastric acid. It is a thing. After reaching the small intestine, the oils and fats are digested and the capsules are exposed. At this time, because the capsule is a non-digestible material that allows bacteria to pass through,
Since the form of the capsule does not disintegrate even when reaching the small intestine, Bifidobacterium is gradually released from the pores, reaches the large intestine, and continues to be released. Therefore, it becomes possible to orally allow a large amount of bifidobacteria to reach the large intestine and ideally maintain the intestinal bacterial flora. Furthermore, when the edible oil / fat is coated with fructooligosaccharides, it not only has a pleasant mouthfeel upon ingestion, but is also a growth factor for the Bifidobacterium group after reaching the intestine, further activating the Bifidobacterium.

〔実施例〕〔Example〕

以下の実施例におけるビフィズス菌の放出試験として
は、真島英信、生理学、文光堂版、418〜446頁を参照し
た。すなわち、試験経過時間として、胃部30分、小腸
(十二指腸から盲腸)4時間、大腸(盲腸から直腸)13
時間30分とした。実施例においては試験時間を2部分に
大別し、胃部30分、腸部17時間30分の合計18時間とし
た。
Refer to Hidenobu Mashima, Physiology, Bunkodo edition, pp. 418-446 for the release test of Bifidobacteria in the following examples. That is, the elapsed time of the test was as follows: stomach 30 minutes, small intestine (duodenum to cecum) 4 hours, large intestine (cecum to rectum) 13
Time was 30 minutes. In the examples, the test time was roughly divided into two parts, that is, the stomach part was 30 minutes and the intestine part was 17 hours and 30 minutes, for a total of 18 hours.

試験液は日本薬局方10、一般試験法、734頁による第1
液(pH約1.2……胃液相当)、第2液(pH約6.8……腸液
相当)を用い、更に食用油脂被膜を溶解する目的でリパ
ーゼを添加した。
Test liquid is Japanese Pharmacopoeia 10, General Test Method, page 734, No. 1
A liquid (pH about 1.2 ... corresponding to gastric juice) and a second liquid (pH about 6.8 ... corresponding to intestinal fluid) were used, and lipase was added for the purpose of dissolving the edible oil / fat film.

試験後、第2液中に放出されたビフィズス菌の確認に
は、BL寒天培地に試験終了後の試験液を一定量散布し、
嫌気性培養を行い所定培養時間経過後コロニーの存在及
び個数を測定した。
After the test, to confirm the bifidobacteria released in the second liquid, a certain amount of the test liquid after the test was sprayed on the BL agar medium,
Anaerobic culture was carried out, and after the lapse of a predetermined culture time, the presence and number of colonies were measured.

実施例1 カラギナン60重量部、アルギン酸20重量部、ローカスト
ビーンガム10重量部、グルコマンナン10重量部を混練
し、これにグリセリン30重量部を加えて良く混合し、し
めり気のある粉状の天然多糖類・多価アルコール組成物
を得た。
Example 1 60 parts by weight of carrageenan, 20 parts by weight of alginic acid, 10 parts by weight of locust bean gum, and 10 parts by weight of glucomannan were kneaded, and 30 parts by weight of glycerin was added thereto and mixed well to give a squeaky powdery natural substance. A polysaccharide / polyhydric alcohol composition was obtained.

この組成物3重量部を97重量部の水に溶解して粘稠な溶
液とし、この溶液を複数の針が遠隔操作で自由に突出
し、収納されるカプセル型を用いて平均膜厚50〜100μ
のカプセルを製造した。このカプセルは耐熱性であり、
孔の大きさは0.5〜3μであった。このカプセルにビフ
ィズス菌属のロンガム(108個/g)を0.5g挿入し、カプ
セル末端を熱融着して密封した。次いで、融点40℃±2
℃の食用硬化油脂(ショートニング精製牛油、横関油脂
工業(株)製)を被覆した。
3 parts by weight of this composition was dissolved in 97 parts by weight of water to make a viscous solution, and a plurality of needles were freely operated by remote control to project the solution, and the capsule type was used to store an average film thickness of 50-100 μm.
Capsules were manufactured. This capsule is heat resistant,
The size of the pores was 0.5-3μ. 0.5 g of Bifidobacteria longum (10 8 pieces / g) was inserted into this capsule, and the end of the capsule was heat-sealed and sealed. Next, melting point 40 ℃ ± 2
Hardened edible oils and fats (shortening refined beef oil, manufactured by Yokozeki Yushi Kogyo Co., Ltd.) at ℃ were coated.

このカプセルを第1液50ml中、37℃30分間浸漬し、次い
で第2液250mlに17時間30分浸漬した。第2液には市販
のリパーゼ(天野製薬(株)製)0.1gを添加した。浸漬
終了後、浸漬液を種々の倍率に希釈して1mlを採取し、B
L寒天培地(栄研(株)製)に接種後、37℃、72時間嫌
気性培養を行い、コロニーの数を測定した。なお、コロ
ニーの数はシャーレ3枚の平均個数である。
The capsule was immersed in 50 ml of the first liquid at 37 ° C. for 30 minutes, and then in 250 ml of the second liquid for 17 hours and 30 minutes. To the second liquid, 0.1 g of commercially available lipase (manufactured by Amano Pharmaceutical Co., Ltd.) was added. After the immersion, dip the immersion liquid to various magnifications and collect 1 ml.
After inoculating to L agar medium (manufactured by Eiken Co., Ltd.), anaerobic culture was performed at 37 ° C. for 72 hours, and the number of colonies was measured. The number of colonies is the average number of 3 petri dishes.

10,000倍希釈で測定不能個数、100,000倍希釈で80個、
1,000,000倍希釈で5個のコロニーが確認された。
Unmeasurable number with 10,000-fold dilution, 80 with 100,000-fold dilution,
Five colonies were confirmed with a 1,000,000-fold dilution.

実施例2 融点40℃±5℃の食用硬化油脂(食用精製加工油脂、横
関油脂工業(株)製)を被覆した以外は実施例1と同様
にして試験を行った。その結果、10,000倍希釈で測定不
能個数、100,000倍希釈で50個、1,000,000倍希釈で8個
のコロニーが確認された。
Example 2 A test was carried out in the same manner as in Example 1 except that a hardened edible oil / fat having a melting point of 40 ° C. ± 5 ° C. (refined edible oil / fat, manufactured by Yokozeki Yushi Kogyo Co., Ltd.) was coated. As a result, an unmeasurable number was confirmed at 10,000-fold dilution, 50 colonies at 100,000-fold dilution, and 8 colonies at 1,000,000-fold dilution.

比較例1 カプセルを油脂を被覆しなかった点及び第2液にリパー
ゼを添加しなかった以外は実施例1と同様にして試験を
行った。その結果、10倍希釈で測定不能個数、100倍希
釈で50個、1000倍希釈で12個、10,000倍希釈で0個のコ
ロニーが確認された。
Comparative Example 1 A test was conducted in the same manner as in Example 1 except that the capsule was not coated with fat and oil and that lipase was not added to the second liquid. As a result, unmeasurable numbers were confirmed at 10-fold dilution, 50 at 100-fold dilution, 12 at 1000-fold dilution, and 0 at 10,000-fold dilution.

比較例2 従来の技術にしたがい、ビフィズス菌を被覆保護するこ
となく、そのまま実施例1の試験を行った場合には、胃
液により完全に失活し、コロニーは存在しなかった。
Comparative Example 2 According to the conventional technique, when the test of Example 1 was carried out as it is without coating and protecting Bifidobacteria, it was completely inactivated by gastric juice and no colonies existed.

〔発明の効果〕〔The invention's effect〕

本発明により、腸内有用細菌を胃液により失活されるこ
となく腸内に到達させることが可能になり、腸内細菌相
を常に正常に保つことが容易になった。
INDUSTRIAL APPLICABILITY According to the present invention, it becomes possible to allow useful intestinal bacteria to reach the intestine without being inactivated by gastric juice, and it becomes easy to always keep the intestinal bacterial flora normal.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】多価アルコール、糖アルコール、単糖類、
二糖類及びオリゴ糖から選ばれた少なくとも1種の原液
或いは濃厚溶液中で、グルコマンナン、カラギナン、ア
ルギン酸、アルギン酸誘導体、寒天、ローカストビーン
ガム、グアーガム、タマリンド種子多糖類、ペクチン、
キサンタンガム、キチン質及びプルランから選ばれた少
なくとも1種の天然多糖類を、アルカリの存在下或いは
非存在下に、均一に混合して得られた粉末状の天然多糖
類・多価アルコール組成物からなる非消化性フィルム製
カプセル内に耐消化性腸内有用細菌が封入され、上記カ
プセルが胃内温度以上の融点を有する食用油脂で被覆さ
れていることを特徴とする耐消化性腸内有用細菌。
1. A polyhydric alcohol, a sugar alcohol, a monosaccharide,
In at least one stock solution or concentrated solution selected from disaccharides and oligosaccharides, glucomannan, carrageenan, alginic acid, alginic acid derivative, agar, locust bean gum, guar gum, tamarind seed polysaccharide, pectin,
From a powdery natural polysaccharide / polyhydric alcohol composition obtained by uniformly mixing at least one natural polysaccharide selected from xanthan gum, chitin and pullulan in the presence or absence of an alkali. A digestive-resistant enteric useful bacterium characterized in that a digestive-resistant enteric useful bacterium is encapsulated in a non-digestible film capsule, and the capsule is coated with an edible oil having a melting point of gastric temperature or higher. .
【請求項2】カプセルに微細孔を穿設したことを特徴と
する請求項第1項に記載する耐消化性腸内有用細菌。
2. The digestive-resistant intestinal useful bacterium according to claim 1, wherein the capsule has micropores.
【請求項3】腸内有用細菌がビフィズス菌群である請求
項第1項または第2項に記載する耐消化性腸内有用細
菌。
3. The digestive-resistant intestinal useful bacterium according to claim 1 or 2, wherein the intestinal useful bacterium is a group of bifidobacteria.
【請求項4】小腸内で消化される微粒子が非消化性フィ
ルム内に配合されている請求項第1項又は第3項に記載
する耐消化性腸内有用細菌。
4. The digestive-resistant intestinal useful bacterium according to claim 1 or 3, wherein the fine particles digested in the small intestine are blended in a non-digestible film.
【請求項5】多価アルコール、糖アルコール、単糖類、
二糖類及びオリゴ糖から選ばれた少なくとも1種の原液
或いは濃厚溶液中で、グルコマンナン、カラギナン、ア
ルギン酸、アルギン酸誘導体、寒天、ローカストビーン
ガム、グアーガム、タマリンド種子多糖類、ペクチン、
キサンタンガム、キチン質及びプルランから選ばれた少
なくとも1種の天然多糖類を、アルカリの存在下或いは
非存在下に、均一に混合して得られた粉末状の天然多糖
類・多価アルコール組成物の水溶液を用いてカプセルを
成形し、しかる後、該カプセルを胃内温度以上の融点を
有する食用油脂で被覆することを特徴とする耐消化性腸
内有用細菌の製法。
5. A polyhydric alcohol, a sugar alcohol, a monosaccharide,
In at least one stock solution or concentrated solution selected from disaccharides and oligosaccharides, glucomannan, carrageenan, alginic acid, alginic acid derivative, agar, locust bean gum, guar gum, tamarind seed polysaccharide, pectin,
A powdery natural polysaccharide / polyhydric alcohol composition obtained by uniformly mixing at least one natural polysaccharide selected from xanthan gum, chitin and pullulan in the presence or absence of an alkali. A method for producing a digestive-resistant enteric useful bacterium, which comprises molding a capsule using an aqueous solution, and then coating the capsule with an edible oil / fat having a melting point of gastric temperature or higher.
【請求項6】カプセル成形と同時にまたはカプセル成形
後に、該カプセルに微細孔を穿設し、しかる後、食用油
脂で被覆することを特徴とする請求項第5項に記載する
耐消化性腸内有用細菌の製法。
6. The digestive-resistant intestinal tract according to claim 5, characterized in that the capsules are provided with fine pores at the same time as or after the capsule molding and then covered with edible oil and fat. How to make useful bacteria.
JP1210102A 1989-08-16 1989-08-16 Digestion-resistant enteric useful bacteria and method for producing the same Expired - Fee Related JPH06101994B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1210102A JPH06101994B2 (en) 1989-08-16 1989-08-16 Digestion-resistant enteric useful bacteria and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1210102A JPH06101994B2 (en) 1989-08-16 1989-08-16 Digestion-resistant enteric useful bacteria and method for producing the same

Publications (2)

Publication Number Publication Date
JPH0376561A JPH0376561A (en) 1991-04-02
JPH06101994B2 true JPH06101994B2 (en) 1994-12-14

Family

ID=16583849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1210102A Expired - Fee Related JPH06101994B2 (en) 1989-08-16 1989-08-16 Digestion-resistant enteric useful bacteria and method for producing the same

Country Status (1)

Country Link
JP (1) JPH06101994B2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69834251T2 (en) 1997-07-05 2007-01-04 Société des Produits Nestlé S.A. Frozen dessert containing lactic acid bacteria and fermentable fiber
WO2002085415A1 (en) 2001-04-17 2002-10-31 Biomatrix, Inc Non-digestible sugar-coated products and process
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
JP4135505B2 (en) * 2003-01-14 2008-08-20 株式会社生活文化舎 Food for promoting colonization and growth of useful intestinal bacteria
EP1621211A1 (en) * 2003-05-02 2006-02-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Soft capsule film and soft capsule
JP2004345999A (en) * 2003-05-21 2004-12-09 Taiko Pharmaceutical Co Ltd Bacterial cell preparation composition
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
WO2006103698A1 (en) * 2005-03-31 2006-10-05 Council Of Scientific & Industrial Research 'edible films and coatings based on fructooligosaccharides with probiotic properties'
ITMI20062286A1 (en) * 2006-11-28 2008-05-29 Anidral Srl A COMPOSITION FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE PRINCIPLES IN GYNECOLOGICAL AND RECTAL AREA AS WELL AS ITS USES
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2578088A1 (en) 2011-10-06 2013-04-10 Nestec S.A. Edible web comprising microorganisms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59220175A (en) * 1983-05-28 1984-12-11 Furointo Sangyo Kk Coating method for health foods
JPS6110508A (en) * 1984-06-26 1986-01-18 Mitsubishi Acetate Co Ltd Capsule and its production
JPS63246333A (en) * 1987-03-31 1988-10-13 Toyo Kapuseru Kk Intestine-activating type soft capsule preparation mainly containing components resisting pantothenic acid deficiency

Also Published As

Publication number Publication date
JPH0376561A (en) 1991-04-02

Similar Documents

Publication Publication Date Title
JPH06101994B2 (en) Digestion-resistant enteric useful bacteria and method for producing the same
KR101902035B1 (en) Protection of microbial cells from acidic degradation
TWI508754B (en) Capsule which disintegrates specifically in large intestine
JP4444496B2 (en) Low temperature coating
EP0882449B1 (en) Sustained release capsule and method for preparing the same
US10206884B2 (en) Microcapsules with polymeric coating comprising a lipid and an active agent
JPH0441434A (en) Lactobacillus tablet provided with enteric coating
JP2014223081A (en) Emulsified food composition
JP2010535767A (en) Nutritional dosage unit
US10493036B2 (en) Enteric capsule
CN106456558A (en) Method of producing enteric soft capsule
US20240082168A1 (en) Controlled drug release formulation
JP2931811B2 (en) Sustained release capsule
JPH0482827A (en) Entero-soluble capsule
JP2021100917A (en) Soft capsule film, soft capsule, and production method of soft capsule
JP6243276B2 (en) Hard capsule formulation with improved acid resistance of the drug substance
JP5250285B2 (en) Oral dressing, edible container and oral product using them
JP2021114952A (en) Enteric composition, food/beverage containing enteric composition, method for controlling disintegration time for enteric composition, and method for manufacturing enteric composition
SI1951290T1 (en) Agent for use in the case of fructose intolerance
JPH03232815A (en) Drug capsule for enteropathy and its production
JPS63246333A (en) Intestine-activating type soft capsule preparation mainly containing components resisting pantothenic acid deficiency
JPH0473414B2 (en)
Kulkarni et al. CODES Technology: A Novel Approach for Colon Target-A Review Article
JP2001354555A (en) Prophylactic agent for disease
WO2025095851A1 (en) Stimulation of the gut microbiota to produce vitamins

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081214

Year of fee payment: 14

LAPS Cancellation because of no payment of annual fees